Catalyst Pharmaceuticals
CPRX
$15.10
Share price
-1.53%
Change (1 day)
-15.24%
Change (1 year)
Categories
Earnings for Catalyst Pharmaceuticals (CPRX)
Earnings in 2023 (TTM): $94.51 M
According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $94.51 M. In 2022 the company made an earning of $0.10 B an increase over its 2021 earnings that were of $52.66 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Catalyst Pharmaceuticals from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $94.51 M | -9.75% |
| 2022 | $0.10 B | 98.83% |
| 2021 | $52.66 M | 25.73% |
| 2020 | $41.88 M | 25.38% |
| 2019 | $33.4 M | -198.25% |
| 2018 | -$34.01 M | 84.68% |
| 2017 | -$18.42 M | 1.88% |
| 2016 | -$18.08 M | -10.68% |
| 2015 | -$20.24 M | 30.46% |
| 2014 | -$15.51 M | 27.6% |
| 2013 | -$12.16 M | 198.17% |
| 2012 | -$4.08 M | -36.22% |
| 2011 | -$6.4 M | 59.52% |
| 2010 | -$4.01 M | -44.68% |
| 2009 | -$7.25 M | -31.45% |
| 2008 | -$10.57 M | 155.21% |
| 2007 | -$4.14 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 17,857.70% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | 3,356.74% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.66 B | 6,951.03% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$0.53 B | -650.30% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.27 B | -379.16% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.18 B | 99.51% | 🇺🇸 USA |